Form 8-K - Current report:
SEC Accession No. 0001193125-24-144049
Filing Date
2024-05-21
Accepted
2024-05-21 17:28:36
Documents
13
Period of Report
2024-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d786039d8k.htm   iXBRL 8-K 38920
  Complete submission text file 0001193125-24-144049.txt   162170

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240521.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240521_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240521_pre.xml EX-101.PRE 11276
17 EXTRACTED XBRL INSTANCE DOCUMENT d786039d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 24970862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)